抗菌药物耐药性与巨大鸿沟:全球北方与全球南方在优先事项和议程上的不平等威胁抗菌药物耐药性的全球减缓
本文为观点文章,作者认为全球北方与全球南方在资源、需求和优先事项上的分歧直接威胁抗菌药物耐药性大流行的减缓成功。证据提示需优先支持全球南方的感染预防干预(清洁用水与安全卫生、提高疫苗覆盖率、加强食品生产感染预防措施),而非全球北方聚焦的新抗生素研发,并重新校准全球资金资源。作者呼吁全球领导者纠正当前应对措施。
要点
- 全球北方与全球南方在抗菌药物耐药性应对上的资源与优先事项分歧直接威胁全球减缓成功。
- 作者主张优先支持全球南方的感染预防干预,而非仅聚焦全球北方的新抗生素研发。
- 作者呼吁重新校准全球资金资源并纠正当前应对措施。
核心结论
- 作者认为全球北方与全球南方在抗菌药物耐药性应对上的资源、需求和优先事项分歧直接威胁减缓成功,呼吁全球领导者纠正当前应对措施。
研究设计与样本
- 本文为观点文章(Viewpoint),未报告系统检索或样本量。
主要发现
- 作者指出全球北方聚焦新抗生素研发,而全球南方需要清洁用水与安全卫生、提高疫苗覆盖率及加强食品生产感染预防措施。
临床怎么用
- 作者建议优先和支持全球南方的感染预防干预,并重新校准全球资金资源以 addressing 该需求。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions required to mitigate the antimicrobial resistance pandemic are a direct threat to success. We argue that evidence suggests a need to prioritise and support infection prevention interventions (ie, clean water and safe sanitation, increased vaccine coverage, and enhanced infection prevention measures for food production in the Global South contrary to the focus on research and development of new antibiotics in the Global North) and to recalibrate global funding resources to address this need. We call on global leaders to redress the current response, which threatens mitigation of the antimicrobial resistance pandemic.
引用
- Mendelson M, Laxminarayan R, Limmathurotsakul D, et al. Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance. Lancet Glob Health. 2024. PMID: 38278160. doi:10.1016/S2214-109X(23)00554-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。